HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
A thin endometrium is one of the most difficult problems encountered in assisted reproduction
every day practice Regarding the proliferative phase, several ways of treatment have been
undertaken to circumvent thin endometrium trying to increase thickness with questionable
results.
The objective of the current study will be whether a daily dose of 150 IU (international
units) of human chorionic gonadotropin (HCG) for seven days concomitant with estrogen
administration in estrogen replacement cycles can increase the endometrial thickness and
improve pregnancy outcome.